Atorvastatin Calcium
Product Images NDC 70934-841

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70934-841). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

70934 841 90 Master Bottle Label Approval Rev A 05 21

Atorvastatin Calcium Tablets USP 80 mg label from Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The label indicates a 90-tablet bottle, prescription only, with storage instructions to keep at 20° to 25°C (68° to 77°F). It includes NDC 70934-841-90 and advises to see the package insert for dosage information.*

FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

A line graph comparing cumulative incidence (%) over years between Atorvastatin and placebo groups. The x-axis represents years up to 3.5, and the y-axis shows cumulative incidence from 0.0 to 4.0%. The solid line for Atorvastatin shows lower incidence than the dashed placebo line. A hazard ratio (HR) of 0.64 with confidence intervals and p-value is displayed on the graph.*

FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

A cumulative hazard graph comparing Atorvastatin and Placebo over a four-year follow-up period. The x-axis represents time to first primary endpoint in years, and the y-axis shows cumulative hazard percentage. The graph shows lower cumulative hazard for Atorvastatin compared to Placebo, with a reported hazard ratio of 0.63 (0.48-0.83) and p-value of 0.001.*

FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

A line graph showing the percentage of subjects experiencing events over time for Atorvastatin 10 mg and 80 mg doses. The x-axis represents time to first major cardiovascular endpoint in years, ranging from 0 to 5 years. The y-axis shows the percentage of subjects experiencing an event, from 0 to 0.2%. Two lines indicate comparisons between 10 mg (dashed line) and 80 mg (solid line) of Atorvastatin, with the 80 mg dose showing a lower event rate over time. Hazard ratio (HR) 0.78 (0.69-0.89) and P value 0.0002 are noted on the graph.*

FDA Label Image

Atorvastatin-st (Atorvastatin St)

Chemical structure of atorvastatin calcium showing its molecular configuration including aromatic rings, hydroxyl groups, and calcium ion complexation with 3 water molecules (trihydrate). This diagram represents the active ingredient atorvastatin calcium.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.